Organogenesis Holdings Inc. Class A (ORGO)

NASDAQ · Manufacturing · Pharmaceutical preparations

$1.39−$0.0300 (−2.11%)As of the Sep 25, 2026 close; data may be delayed.

ORGO price, last 12 months

Sep 15, 2025Sep 25, 2026

Daily closes over the last 260 trading sessions: −72.0%. Highest close $6.54 on Nov 10, 2025, lowest $1.36 on Sep 17, 2026. Market data may be delayed.

Key stats

Previous close: $1.42
Open: $1.43
Day range: $1.36 – $1.44
52-week range: $1.34 – $7.08
Volume: 539.5K
Avg volume (20 days): 664K
Market cap: $181.4M

Performance

1W−2.1%

1M−20.6%

3M−42.8%

6M−42.6%

YTD−73.2%

1Y−71.6%

vs S&P 500, 1Y−88.4 pts

Technicals and fundamentals

About Organogenesis Holdings Inc. Class A

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Sector: Manufacturing
Industry: Pharmaceutical preparations
Listed on: NASDAQ
Market cap: $181.4M

organogenesis.com

Technicals and fundamentals

Technicals

RSI (14)33.1mid-range

vs 50-day average−26.6%

vs 200-day average−51.1%price below both averages

MACDAbove signal

Daily range (ATR)6.4%average true range, % of price

52w low $1.3452w high $7.08

Where price sits today against its own history. A description, not a forecast.

Valuation

P/E (trailing)—

P/E (forward)−4.7

PEG—

Price / sales0.41

Price / book1.26

EV / EBITDA—

Company figures as of Sep 23, 2026.

Analysts

Consensus—— on 1 (strong buy) to 5 (strong sell)

Analysts1

Average target$2.00+43.9% from today

Price targets are opinions and tend to lean optimistic. Only 1 analyst cover it, so one view moves the average.

Earnings

Quarter ended	EPS	YoY	Revenue	YoY
Jun '26	−0.77	—	$43.8M	−57%
Mar '26	−0.44	—	$37.2M	−57%
Dec '25	0.27	—	$225.6M	—
Sep '25	0.11	+22%	$150.9M	+31%
Jun '25	−0.10	—	$101M	−22%
Mar '25	−0.17	—	$86.7M	−21%
Sep '24	0.09	+350%	$115.2M	+6%
Jun '24	−0.13	−425%	$130.2M	+11%

By the quarter each report covers, against the same quarter a year earlier. Growth from a loss is left blank: a percentage there reads backwards.

Seasonality

-9.7

+9.9

-17.5

-4.7

+9.3

+1.7

+15.6

-18.5

-3.7

-10.7

+10.1

+6.6

Average return in each calendar month, Oct 31, 2021 to Aug 31, 2026. 5 years is 5 observations a month: too few to call a pattern, so read it as history, not a calendar to trade.

Organogenesis Holdings Inc. Class A (ORGO)

ORGO price, last 12 months

Key stats

Performance

Technicals and fundamentals

About Organogenesis Holdings Inc. Class A

Organogenesis Holdings Inc. Class A (ORGO)

ORGO price, last 12 months

Key stats

Performance

Technicals and fundamentals

Technicals

Valuation

Analysts

Earnings

Seasonality

About Organogenesis Holdings Inc. Class A

News

Technicals

Valuation

Analysts

Earnings

Seasonality

News

ORGO price, last 12 months

Key stats

Performance

Technicals and fundamentals

About Organogenesis Holdings Inc. Class A

Recent news about ORGO

Chart ORGO with indicators, scan for setups and get alerts

ORGO price, last 12 months

Key stats

Performance

Technicals and fundamentals

Technicals

Valuation

Analysts

Earnings

Seasonality

About Organogenesis Holdings Inc. Class A

Recent news about ORGO

News

Chart ORGO with indicators, scan for setups and get alerts

Technicals

Valuation

Analysts

Earnings

Seasonality

News